KURA Should I Buy

Not a good buy right now for an impatient trader. KURA is sitting right on near-term support (~8.14) with a potentially oversold setup, but the broader tape is still weak (below pivot 8.67), there are no fresh news catalysts this week, and insider selling has accelerated sharply. Options positioning is bullish (heavy call skew), yet that looks more like residual optimism after the prior FDA approval/analyst upgrades than a new trigger today. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today. If you must act immediately, this is more of a “wait for confirmation / avoid chasing” tape than a high-conviction buy-now setup.

Price is 8.15 (closed), slightly below prior close and below the key pivot (8.67), implying the stock remains in a near-term downtrend/repair phase. - **Support/Resistance**: S1 = 8.136 (price is essentially sitting on it); if it breaks, next support S2 = 7.805. Upside levels: R1 = 9.205, R2 = 9.536. - **RSI (6)**: 32.58, near oversold (can support a short-term bounce), but not a confirmed reversal by itself. - **MACD**: Histogram is negative (-0.0545) but contracting, suggesting bearish momentum is weakening—still not a definitive buy signal. - **Moving averages**: Converging MAs typically indicate indecision/transition; combined with price below pivot, the setup is “base-building” at best. Overall: technically this is a fragile support test; a bounce is possible, but the trend is not yet convincingly bullish.